| 2-Methoxy-4-(3-methyl-1-(4-(trifluoromethyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl)phenol |
ML303 |
1638211-04-7 |
| XMD17-51 |
XMD-17-51 |
1628614-50-5 |
| MW-150 |
MW-150 |
1628502-91-9 |
| CC-90003 |
1621999-82-3 |
1621999-82-3 |
| KY-226 |
抑制剂 |
1621673-53-7 |
| Creatine riboside |
Creatine riboside |
1616693-92-5 |
| UNC2541 |
UNC2541 |
1612782-86-1 |
| [4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate |
PDP-C1-PH-VAL-CIT |
1610769-13-5 |
| SEL120-34A |
1609522-33-9 |
1609522-33-9 |
| Benzeneacetic acid, 4-[[2-(3-chlorophenyl)-6-(trifluoromethyl)-4-pyridinyl]methyl]- |
BPN14770 |
1606974-33-7 |
| GSK199 (hydrochloride) |
GSK199;GSK 199 |
1549811-53-1 |
| Adomeglivant |
1488363-78-5 |
1488363-78-5 |
| NCGC607 |
NCGC607 |
1462267-07-7 |
| PU-H54 |
化合物PU-H54 |
1454619-13-6 |
| Azido-PEG5-CH2CO2t-butyl ester |
AZIDO-PEG5-CH2CO2TBU |
1448451-72-6 |
| 5-((1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one |
LIFIRAFENIB |
1446090-79-4 |
| ML 254 |
ML 254 |
1428630-86-7 |
| TMP778 |
化合物TMP-778 |
1422171-08-1 |
| 2,5-Dioxopyrrolidin-1-yl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
NHPI-PEG4-C2-NHS ESTER |
1415328-95-8 |
| BRD6688 |
BRD6688 |
1404562-17-9 |
